SCHEMBL30622374

SCHEMBL30622374

C=CC(=O)N1CCn2nc(-c3ccc(Cl)cc3F)c(-c3ccncc3)c2[C@H]1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.39
▸ EGFR P00533 5/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ PRKACA P17612 1/20 0.37
▸ FRK P42685 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ CSNK1D P48730 1/20 0.37
▸ MINK1 Q8N4C8 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ PDE4A P27815 2/20 0.35
▸ PDE4B Q07343 2/20 0.35
▸ PDE4C Q08493 2/20 0.35
▸ KRAS P01116 6/20 0.34
▸ GHSR Q92847 1/20 0.34
▸ TGFBR1 P36897 1/20 0.33
▸ BTK Q06187 1/20 0.33
▸ CCNK O75909 1/20 0.33
▸ CDK12 Q9NYV4 1/20 0.33
▸ MAPK11 Q15759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645237 1.00 BCHE (0.39) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL26645397 0.90 BCHE (0.41) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL30623095 0.86 BCHE (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL26644959 0.86 BCHE (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL30622884 0.86 BCHE (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL26644907 0.86 BCHE (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL30622301 0.86 EGFR (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL26645286 0.86 EGFR (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL30622336 0.86 EGFR (0.38) BCHEEGFRMAP4K4PRKACAFRK
SCHEMBL30622978 0.84 CYP3A4 (0.39) BCHEEGFRMAP4K4PRKACAFRK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP claimed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO claimed
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback